DaVita Inc V.DVA

Primary Symbol: DVA

Healthcare

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

NYSE:DVA - Post by User

DaVita Inc > volume

<< Previous

Bullboard Posts

Next >>

Comment by QcTraderon Oct 29, 2017 11:10pm

46 Views

Post# 26874656

RE:RE:RE:RE:volume

I think its important for investors to have a look at their partner AvantiRX

https://www.avantirx.com/home.html

These boys are not at their first rodeo!

We should also mention the joint venture created by DVA + AvantiRX is 100% funded by AvantiRX!!

Now this is very BIG imo!

Their connection with WEED makes it a very interesting play if you weight in the recent WEED + Constallation Brands deal.

DVA has the experience in extraction, formulation, processing, now that they teamed up with AvantiRX, this provides them with an instant exemption 56 from Health Canada!

Cheers to some green!

Chefboy69 wrote: I agree with everything you say...
with this...Delivra Signs Exclusive Licensing Deal with ARA-Avanti Rx Analytics for Hemp Non-Psychoactive Cannabinoid, Terpene and Flavonoid Formulations and Products

and this..The completion of a licensing agreement with Canopy Growth Corporation, our second licensing agreement for the transdermal delivery of medical cannabis, addresses the growing demand for topical cannabis as a therapeutic option for a range of conditions. Through this collaboration, Delivra will offer consumers a unique product suite. We are excited at the opportunity of licensing these natural and Rx products globally," said Dr. Joseph Gabriele, CEO of Delivra Corp.

and funding from PEI and possible deals with Canada's Island Garden Inc.
DVA has lab in PEI...

and products on AMAZON...https://www.amazon.ca/LivRelief-Pain-Relief-Cream-Brand/dp/B0045PCFW2

and so many other things going on with this company...

I can't belive i was able to buy this stock today for 0.27???
crazy cheap

Voteliberal wrote: there has been no NR since oct 4. I expect in the next few years we will be multiples higher then were we are now. in the near future I believe it won't go much lower. Pick a company you believe in and stick it out. with the market cap and outstanging shares being so low it really takes no money at all to swing the price of this stock around.